Skip to main content

Table 2 Patient characteristics II

From: Cerebral perfusion in sepsis-associated delirium

Patient

Timea

Intubated

PaO2b

Glcc

Heparin, IU/24 hours

NAd

DOBe

Steroidsf

Sedationg

1

30

 

10.2 (8.0)

13.3

10,000

   

L, H

2

42

 

13.6 (11.0)

8.3

22,000

   

L, H, Q

3

39

X

9.2 (7.6)

8.0

10,000

  

X

M, F

4

37

 

8.3 (8.3)

6.3

LMWH 5,000

  

X

P, M

5

30

X

11.3 (9.1)

9.6

15,000

18

  

P, M

6

39

X

16.2 (9.3)

5.3

10,000

14

 

X

P, Mi, M

7

29

 

11.5 (8.4)

6.5

20,000

7

300

 

None

8

42

 

8.6 (6.8)

5.3

20,000

11

400

 

M

9

48

X

13.4 (12.1)

6.9

10,000

26

 

X

Mi, M

10

46

X

15.0 (10.2)

7.0

LMWH 2,500

20

 

X

Mi, F, M

11

48

X

11.3 (8.6)

5.7

LMWH 5,000

18

 

X

P, M, R

12

42

 

18.5 (15.1)

7.6

15,000

   

P, M

13

25

X

19.2 (9.3)

4.8

LMWH 5,000

   

P, F

14

6

 

13.8 (12.0)

6.7

None

  

X

None

15

44

 

11.7 (11.6)

6.1

LMWH 5,000

 

300

 

M, H

16

26

 

11.8 (11.2)

6.8

LMWH 5,000

   

None

  1. Patients 1 to 12: sepsis-associated delirium present; patients 13 to 16: no sepsis-associated delirium. aTime, time interval (hours) between admission to the intensive care unit and measurements. bPaO2, partial pressure of oxygen during measurement (lowest recorded value between admission to the intensive care unit and measurement). cGlc, blood glucose levels (mmol/L). dNA, noradrenaline: μg/minute during measurement. eDOB, dobutamine: μg/minute during measurement. fPatient 3: 3 × 100 mg hydrocortisone per 24 hours; patient 14: 25 mg methylprednisolone per day; all other patients: 4 × 50 mg hydrocortisone per 24 hours. gF, fentanyl; H, haloperidol; L, lorazepam; M, morphine; Mi, midazolam; P, propofol; Q, quetiapine; R, remifentanil. LMWH, low-molecular-weight heparin.